aGrowth-competition experiments were initiated by infecting 2×106 BHK-21 cells with 7×105 PFU of FMDV Wt and FMDV 3D(SSI) in the absence of drugs or in the presence either of 5000 µM R, 2000 µM FU or

NIAID Data Ecosystem30

Dataset from An Open-Label Study to Evaluate the Safety and Efficacy of the Coadministration of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) With Ribavirin (RBV) in Adults With Chronic Hepatitis C Virus Genotype 4 Infection in Egypt

丙型肝炎治疗

药物临床试验

This study evaluates the efficacy and safety of ABT-450/r/ABT-267 with RBV in treatment-naive and treatment-experienced HCV GT4 subjects without or with compensated cirrhosis.

NIAID Data Ecosystem10

Table 1_Characteristics of pediatric interventional drug trials registered between 2015 and 2024 on ClinicalTrials.gov.xlsx

药物临床试验

药物剂型与给药途径分析

AimThis study comprehensively analyzed the characteristics and development trends of pediatric interventional drug clinical trials registered between 2015 and 2024, with a focus on pharmaceutical char

NIAID Data Ecosystem40

A Randomized, Placebo-Controlled, Double-Blind (Sponsor Unblinded) Study to Investigate Protective Effects of GSK1278863 on Eccentric Exercise Induced Muscle Damage in Healthy Male Volunteers

药物临床试验

运动性肌肉损伤

As per non-clinical studies, prolyl hydroxylase inhibitor GSK1278863 can protect muscle from unaccustomed exercise induced muscle damage and enhance functional muscle repair. This study is designed to

DataCite Commons2025-04-01 更新30